CRI's largest grant to a single investigator will support development of microchip-based research models of cancer and the immune system
The Focused Ultrasound Foundation (FUSF) and the Cancer Research Institute (CRI) are establishing a partnership with the goal of advancing the development of new focused ultrasound (FUS) and cancer immunotherapy treatments.
The Cancer Research Institute 2017 Immunotherapy Patient Summit Series will travel to five U.S. cities to provide free educational programming designed for cancer patients and caregivers who are seeking to learn more about cancer immunotherapy and clinical trials.
Cancer Research Institute to bring together cancer patients, leading immunotherapy manufacturers, and Highland Falls community members for Second Annual Answer to Cancer Cycling and 5K Run/Walk Event Sponsored by Bristol-Myers Squibb on Saturday, June 10, 2017
30 days of educational and awareness programming and special events for patients, caregivers, and the public about cancer immunotherapy, clinical trials, and the need to fund more research
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
CRI scientists Dr. Michele Ardolino and Dr. David Raulet showed that Natural Killer cells can help eliminate tumors after checkpoint immunotherapy treatment even in the absence of T cells.
The third installment of the Rational Combinations 360 conference, which will be held in Philadelphia September 13-14, seeks to improve the design and application of combination immunotherapies for patients